Hudson Robotics and Art Robbins Instruments, a global laboratory automation solutions provider, and Argosy Healthcare Partners portfolio company, have announced that they have appointed Matt Tallman as Senior Vice President of Sales and Marketing.
Matt brings a wealth of experience and expertise to Hudson with a proven track record of success in driving revenue growth and brand awareness in the Life Sciences and Clinical space. He joins Hudson from Waters Corporation, where he built and led a team driving above market growth for their laboratory automation business. He also spent over a decade with Thermo Fisher Scientific in various sales and marketing leadership roles of increasing responsibility.
“We are thrilled to welcome Matt to the team,” said Andrew Witschi, CEO of Hudson, “He is a visionary leader with a deep understanding of our industry and a passion for the customer. We are confident that he will be instrumental in driving our continued growth and success.”
“I am excited to join the team. We have a tremendous opportunity to provide quality and impactful lab automation solutions to our customers allowing them to better solve scientific challenges in the world. I look forward to bringing my best self to the role, helping the entire Hudson team realize their potential, and driving continued growth in the market for Hudson,” said Matt.
Matt holds a Bachelor’s degree in Biology from West Virginia University and holds an MBA focused in Marketing and Organizational Behavior from the University of Pittsburgh, Katz Graduate School of Business.
Hudson
Hudson, formed in 2022 through the combination of Hudson Robotics and Art Robbins Instruments, and headquartered in Springfield, New Jersey, designs and assembles liquid handling, microplate automation, laboratory robotics, customized software-driven laboratory automation solutions and consumables. Hudson’s instruments are used in drug discovery, clinical research, protein crystallization, high-throughput experimentation and pharmaceutical development. HR sells its software, instruments, consumables, and workstations primarily to the pharma, biopharma, academic and OEM end markets.
